Annual Current Assets
$514.17 M
+$437.66 M+572.01%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual total current assets is $514.17 million, with the most recent change of +$437.66 million (+572.01%) on December 31, 2023.
- During the last 3 years, MLTX annual current assets has risen by +$504.53 million (+5235.51%).
- MLTX annual current assets is now at all-time high.
Performance
MLTX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$512.32 M
-$24.57 M-4.58%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly total current assets is $512.32 million, with the most recent change of -$24.57 million (-4.58%) on September 30, 2024.
- Over the past year, MLTX quarterly current assets has dropped by -$24.57 million (-4.58%).
- MLTX quarterly current assets is now -7.46% below its all-time high of $553.59 million, reached on March 31, 2024.
Performance
MLTX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
MLTX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +572.0% | -4.6% |
3 y3 years | +5235.5% | +5216.3% |
5 y5 years | +5235.5% | +5216.3% |
MLTX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +5235.5% | -7.5% | +5216.3% |
5 y | 5-year | at high | +5235.5% | -7.5% | +5216.3% |
alltime | all time | at high | +5235.5% | -7.5% | +5216.3% |
MoonLake Immunotherapeutics Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $512.32 M(-4.6%) |
Jun 2024 | - | $536.88 M(-3.0%) |
Mar 2024 | - | $553.59 M(+7.7%) |
Dec 2023 | $12.37 M | $514.17 M(+2.8%) |
Sep 2023 | - | $500.01 M(-1.3%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $506.37 M(+661.4%) |
Mar 2023 | - | $66.50 M(-13.1%) |
Dec 2022 | $332.00 K(+626.5%) | $76.51 M(-13.6%) |
Sep 2022 | - | $88.54 M(-10.0%) |
Jun 2022 | - | $98.38 M(+920.9%) |
Dec 2021 | $45.70 K | $9.64 M |
FAQ
- What is MoonLake Immunotherapeutics annual total current assets?
- What is the all time high annual current assets for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual current assets year-on-year change?
- What is MoonLake Immunotherapeutics quarterly total current assets?
- What is the all time high quarterly current assets for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly current assets year-on-year change?
What is MoonLake Immunotherapeutics annual total current assets?
The current annual current assets of MLTX is $514.17 M
What is the all time high annual current assets for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual total current assets is $514.17 M
What is MoonLake Immunotherapeutics annual current assets year-on-year change?
Over the past year, MLTX annual total current assets has changed by +$437.66 M (+572.01%)
What is MoonLake Immunotherapeutics quarterly total current assets?
The current quarterly current assets of MLTX is $512.32 M
What is the all time high quarterly current assets for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly total current assets is $553.59 M
What is MoonLake Immunotherapeutics quarterly current assets year-on-year change?
Over the past year, MLTX quarterly total current assets has changed by -$24.57 M (-4.58%)